BCMA
Advertisement
Teclistamab and talquetamab, two investigational bispecific antibodies, showed promising responses for the treatment of ...
Findings from the CARTITUDE clinical program found that ciltacabtagene autoleucel (cilta-cel), an anti-B cell maturation ...
DocWire News spoke with Nikhil Munshi, MD, Professor at Harvard Medical School and medical oncologist at the Dana-Farber ...
Pfizer Inc. has paused a clinical trial of a drug for multiple myeloma (MM) after several patients treated with the ...
DocWire News sat down with Natalie Callander, MD, professor and director of the Myeloma Clinical Program at the ...
Shaji Kumar, MD, consultant in the Division of Hematology and professor of medicine at Mayo Clinic Cancer Center in ...
Shaji Kumar, MD, consultant in the Division of Hematology and professor of medicine at Mayo Clinic Cancer Center in ...
Shaji Kumar, MD, consultant in the Division of Hematology and professor of medicine at Mayo Clinic Cancer Center in ...
Belantamab mafodotin, an investigational anti-B-cell maturation antigen monoclonal antibody-drug conjugate, demonstrated ...
A B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy resulted in a 100% response rate among ...
A combination of humanized anti-CD19 and anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.